Literature DB >> 15039534

The central region of human immunodeficiency virus type 1 p6 protein (Gag residues S14-I31) is dispensable for the virus in vitro.

Gabriela Bleiber1, Solange Peters1, Raquel Martinez1, Dusan Cmarko2, Pascal Meylan3,1, Amalio Telenti3,1.   

Abstract

The human immunodeficiency virus type 1 p6 region encodes p6(Gag) and the transframe p6(Pol) protein. The Gag frame encodes an N-terminal late assembly L domain and a C-terminal Vpr binding domain. In the Pol frame, substitution at a C-terminal motif decreases protease autocleavage. The role of the highly polymorphic central region of p6, comprising amino acids S14-I31 (p6(Gag)) and R20-D39 (p6(Pol)), is unclear. Analysis of this central region demonstrated that 35 % of p6(Gag) appears to be dispensable for virus propagation in vitro and smaller deletion and insertion polymorphisms can be tolerated in vivo. Extensive Pol deletion (deltaR20-D39, 42 % of p6(Pol)) did not alter protease autocleavage.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15039534     DOI: 10.1099/vir.0.19576-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  7 in total

1.  Uncoupling human immunodeficiency virus type 1 Gag and Pol reading frames: role of the transframe protein p6* in viral replication.

Authors:  Andreas Leiherer; Christine Ludwig; Ralf Wagner
Journal:  J Virol       Date:  2009-04-29       Impact factor: 5.103

2.  C-Terminal HIV-1 Transframe p6* Tetrapeptide Blocks Enhanced Gag Cleavage Incurred by Leucine Zipper Replacement of a Deleted p6* Domain.

Authors:  Fu-Hsien Yu; Kuo-Jung Huang; Chin-Tien Wang
Journal:  J Virol       Date:  2017-04-28       Impact factor: 5.103

3.  Heterologous late-domain sequences have various abilities to promote budding of human immunodeficiency virus type 1.

Authors:  David E Ott; Lori V Coren; Tracy D Gagliardi; Kunio Nagashima
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Understanding HIV-1 protease autoprocessing for novel therapeutic development.

Authors:  Liangqun Huang; Chaoping Chen
Journal:  Future Med Chem       Date:  2013-07       Impact factor: 3.808

5.  Transmission of new CRF07_BC strains with 7 amino acid deletion in Gag p6.

Authors:  Meng Zhefeng; Hu Huiliang; Qiu Chao; Sun Jun; Lu Jianxin; Zhang Xiaoyan; Xu Jianqing
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

6.  Slow immunological progression in HIV-1 CRF07_BC-infected injecting drug users.

Authors:  Pi-Han Lin; Chung-Chih Lai; Jia-Ling Yang; Hui-Lin Huang; Ming-Siang Huang; Mao-Song Tsai; Chia-Jui Yang; Chien-Ling Cheng; Yi-Ching Su; Shu-Fang Chang; Wen-Chun Liu; Chien-Ching Hung; Sui-Yuan Chang; Shan-Chwen Chang
Journal:  Emerg Microbes Infect       Date:  2013-12-11       Impact factor: 7.163

Review 7.  How HIV-1 Gag Manipulates Its Host Cell Proteins: A Focus on Interactors of the Nucleocapsid Domain.

Authors:  Jéromine Klingler; Halina Anton; Eléonore Réal; Manon Zeiger; Christiane Moog; Yves Mély; Emmanuel Boutant
Journal:  Viruses       Date:  2020-08-13       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.